SFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study. (3rd October 2022)
- Record Type:
- Journal Article
- Title:
- SFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study. (3rd October 2022)
- Main Title:
- SFlt-1 to PlGF ratio cut-offs to predict adverse pregnancy outcomes in early-onset FGR and SGA: a prospective observational study
- Authors:
- Bonacina, Erika
Armengol-Alsina, Mireia
Hurtado, Ivan
Garcia-Manau, Pablo
Ferrer-Oliveras, Raquel
Monreal, Sonia
Pancorbo, Maria
Mendoza, Manel
Carreras, Elena - Abstract:
- Abstract: This is a prospective, observational study, conducted in a tertiary referral hospital. We enrolled 175 singleton pregnancies with estimated foetal weight below the 10th centile between 20 + 0 and 31 + 6 weeks. Placental growth factor (PlGF), soluble fms‐like tyrosine kinase‐1 (sFlt-1) and fetoplacental circulation were assessed at the time of diagnosis. Receiver operating characteristic curves were used to assess the performance of sFlt-1/PlGF for predicting adverse perinatal outcomes (APO). The optimal cut-offs to predict each adverse outcome were calculated and the resulting areas under the curve (AUC) were compared to those calculated from the cut-off points of 38, 85 and 110. The need for delivery at <30 and <34 weeks and APO were the main outcome measures. The optimal cut-off points to predict APO, delivery <30 and <34 weeks were 24.9, 116.7 and 97.5, respectively. None of them proved to be superior to 38, 85 or 110 for predicting any adverse pregnancy outcome. Impact Statement: What is already known on this subject? Soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth factor (PlGF) are biomarkers of placental dysfunction. High sFlt‐1/PlGF values predict adverse perinatal outcomes in preeclampsia (PE). What do the results of this study add? No specific thresholds have been described to identify early-onset foetal growth restriction (FGR) and small for gestational age (SGA) foetuses at higher risk of adverse outcomes. This study describes theseAbstract: This is a prospective, observational study, conducted in a tertiary referral hospital. We enrolled 175 singleton pregnancies with estimated foetal weight below the 10th centile between 20 + 0 and 31 + 6 weeks. Placental growth factor (PlGF), soluble fms‐like tyrosine kinase‐1 (sFlt-1) and fetoplacental circulation were assessed at the time of diagnosis. Receiver operating characteristic curves were used to assess the performance of sFlt-1/PlGF for predicting adverse perinatal outcomes (APO). The optimal cut-offs to predict each adverse outcome were calculated and the resulting areas under the curve (AUC) were compared to those calculated from the cut-off points of 38, 85 and 110. The need for delivery at <30 and <34 weeks and APO were the main outcome measures. The optimal cut-off points to predict APO, delivery <30 and <34 weeks were 24.9, 116.7 and 97.5, respectively. None of them proved to be superior to 38, 85 or 110 for predicting any adverse pregnancy outcome. Impact Statement: What is already known on this subject? Soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth factor (PlGF) are biomarkers of placental dysfunction. High sFlt‐1/PlGF values predict adverse perinatal outcomes in preeclampsia (PE). What do the results of this study add? No specific thresholds have been described to identify early-onset foetal growth restriction (FGR) and small for gestational age (SGA) foetuses at higher risk of adverse outcomes. This study describes these specific cut-offs and compares their predictive capacity to those described for PE. What are the implications of these findings for clinical practice and/or further research? The sFlt-1/PlGF cut-off points of 38, 85 and 110 might be useful for ruling out the occurrence of APO and the need for elective delivery at <30 and at <34 weeks from the moment of diagnosis in early-onset FGR and SGA. These cut-offs could aid Doppler studies in the distinction between FGR and SGA. … (more)
- Is Part Of:
- Journal of obstetrics and gynaecology. Volume 42:Number 7(2022)
- Journal:
- Journal of obstetrics and gynaecology
- Issue:
- Volume 42:Number 7(2022)
- Issue Display:
- Volume 42, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 42
- Issue:
- 7
- Issue Sort Value:
- 2022-0042-0007-0000
- Page Start:
- 2840
- Page End:
- 2845
- Publication Date:
- 2022-10-03
- Subjects:
- Adverse pregnancy outcomes -- angiogenic factors -- foetal growth restriction -- placental growth factor -- small for gestational age -- soluble fms-like tyrosine kinase-1
Obstetrics -- Periodicals
Gynecology -- Periodicals
618.05 - Journal URLs:
- http://informahealthcare.com/journal/jog ↗
http://informahealthcare.com ↗
http://www.tandf.co.uk/journals/titles/01443615.asp ↗ - DOI:
- 10.1080/01443615.2022.2109956 ↗
- Languages:
- English
- ISSNs:
- 0144-3615
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5025.400000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 26217.xml